Recent studies claim that oxytocin treatment in autism attenuates amygdala activity [220], improves thermo-sensory reactivity and maternal behavior in neonates lacking the autism-associated gene Magel2 [221] or regulates the activities in ventromedial prefrontal cortex to alleviate the social deficits of autism [222]. Here, MAGEL2 is linked to autism.